Corium International Company
Corium International engages in the development of advanced transdermal drug delivery technologies and products.
Estimated Revenue:
$10M to $50M
Funding Status:
M&A
Industry:
PharmTech
Number Of Exists:
N/A
Technology:
Immunotherapy
Founded Date:
1995
Investor Type:
N/A
Headquarters:
Menlo Park, California, United States
Employee Number:
501-1000
Investment Stage:
N/A